SUBSCRIBE
SUBSCRIBE
News   Policy

Dendreon Corporation Shares Halted Ahead of FDA Meeting

March 29, 2007 | 
1 min read
SAN FRANCISCO (MarketWatch) -- Shares of Dendreon Corp. were halted before the start of trading Thursday, ahead of a Food and Drug Administration advisory committee meeting to evaluate Provenge, the company's experimental prostate-cancer drug.

>>> Discuss This Story

Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Canada US crisis concept as a Broken Rope stretched with force and stressed to a decoupling metaphor for pressure on the economic and political relationship between Ottawa and Washington.
Drug pricing
FDA Advances Drug Importation Plan as Canada Moves To Protect Its Supply
May 22, 2025
 · 
2 min read
 · 
Annalee Armstrong
New York City, NY, USA - August 22, 2022: Pfizer world headquarters in New York City, USA. Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation.
Adcomms
Pfizer’s Talzenna Expansion Fails To Earn FDA Advisory Committee’s Support
May 22, 2025
 · 
2 min read
 · 
Tristan Manalac
Pictured: Eli Lilly's biotechnology center in California
Drug pricing
‘We Don’t Believe This Is Right’: Lilly Bristles as CMS Leaves Obesity Drugs Out of Medicare
May 22, 2025
 · 
2 min read
 · 
Tristan Manalac
Cambridge, USA - 16 August 2024. View of Moderna office entrance with logo sign, Biotechnology industry
Vaccines
Moderna Shares Fall as Combo Flu/COVID-19 Vaccine Application Pulled
May 21, 2025
 · 
2 min read
 · 
Dan Samorodnitsky